Nufarm stock gains guidance as FY26 EBITDA reaches AUD 380 million

Published on 09/23/2026 at 04:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Nufarm stock enters September 23, 2026, after FY26 EBITDA guidance of AUD 370 million to AUD 380 million. The midpoint is 25 percent above FY25.

Nufarm, AU000000NUF3, Illustration mit AI erstellt.

Nufarm stock enters September 23, 2026, with the company guiding to underlying FY26 EBITDA of AUD 370 million to AUD 380 million. According to Capital Brief on September 22, 2026, the midpoint of that range is about 25 percent above FY25 underlying EBITDA.

FY26 guidance sets the benchmark

The AUD 370 million to AUD 380 million range gives the market a quantified operating benchmark for fiscal 2026. The midpoint is AUD 375 million, compared with the FY25 base cited by Capital Brief as the reference for the 25 percent increase.

That comparison matters because the guidance links the current investment debate to earnings power rather than to a purely technical share-price move. The upper end of AUD 380 million is the clearest figure for measuring any later change in management expectations.

Stock data define the trading picture

Nufarm stock is listed on the Australian Securities Exchange under the ticker NUF. The current market snapshot and trading range provide the reference for judging how much of the FY26 improvement is already reflected in the shares.

For investors, the key distinction is between the AUD 370 million lower guidance point and the AUD 380 million upper point. A 25 percent year-on-year midpoint comparison leaves operating delivery and the eventual FY26 result as the central measurable checkpoints.

EBITDA range remains the anchor

The shares therefore carry a clearly dated earnings reference from September 22, 2026: underlying FY26 EBITDA of up to AUD 380 million. The 25 percent midpoint improvement over FY25 is the quantified comparison that gives the guidance its significance.